Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Tipranks - Tipranks - Tue Mar 3, 5:24AM CST

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA, with a price target of €42.00.

Claim 50% Off TipRanks Premium

According to TipRanks, Friedrichs is an analyst with an average return of -2.6% and a 41.35% success rate. Friedrichs covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care AG & Co. KGaA, Fresenius SE & Co. KGaA, and Siemens Healthineers AG.

In addition to Deutsche Bank , Fresenius Medical Care AG & Co. KGaA also received a Hold from TipRanks – Google’s Google Health Care GB in a report issued on February 27. However, today, Jefferies maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

See Insiders’ Hot Stocks on TipRanks >>

Based on Fresenius Medical Care AG & Co. KGaA’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of €5.07 billion and a net profit of €327 million. In comparison, last year the company earned a revenue of €5.08 billion and had a net profit of €66.91 million

Read More on GB:0H9X:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).